Newton Biocapital II SA
Newton Biocapital II reported total assets of €24.6m at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jun 2026).
By total assets for 2025, Newton Biocapital II ranks among the 100 largest of the 210 companies in its sector (NACE 6431) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Newton Biocapital II shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +115 % Total assets +112 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Newton Biocapital II's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jun 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 24 May 2023
Newton Biocapital II's financial analysis
- Solvency99.8%sector median: 95.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Newton Biocapital II
12 active director(s) in the register.
and 6 more
Newton Biocapital II's shareholders and holdings →Newton Biocapital II's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.335.513
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0779335513 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 Dec 2021
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 01 Jun 2026
- Activity
- Activities of money market and non-money market investments funds (NACE 64310)
Newton Biocapital II (SA) has been based in Woluwe-Saint-Pierre since 2021, active in: activities of money market and non-money market investments funds. For 2025, it reports a net loss of 824,565 € and equity of €24.6m; its revenue is not published. Its solvency stands at 99.8%, above the median of its sector (95.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Newton Biocapital II
Companies in the same business, of comparable size and area, outside its group.
- Biotech Fonds Vlaanderen Brussels · balance sheet €24.6m
- Bioqube Factory Fund I Other financial service activities, except insurance and pension funding n.e.c. Brussels · balance sheet €68.3m
- Flanders Future Techfund Brussels · balance sheet €32.5m
- Quaestor Biotech Activities of holding companies Roeselare · balance sheet €13.1m
- V-Bio Fund 2 Activities of money market and non-money market investments funds Ghent · balance sheet €51.8m
- KBC Private Partners Life Sciences Activities of holding companies Molenbeek-Saint-Jean · balance sheet €29.9m
- Qbic III Fund Activities of holding companies Ghent · balance sheet €38.5m
- Vives Inter-University Fund Ottignies-Louvain-la-Neuve · balance sheet €25.1m
Frequently asked questions about Newton Biocapital II
What is the revenue of Newton Biocapital II?
Newton Biocapital II files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Newton Biocapital II?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Newton Biocapital II. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0779335513. Its company number (CBE) is 0779.335.513.
Where is the registered office of Newton Biocapital II?
According to the CBE register, the registered office of Newton Biocapital II is in 1150 Woluwe-Saint-Pierre.
What is the equity of Newton Biocapital II?
At the close of the 2025 financial year, the equity of Newton Biocapital II amounts to 24,576,414 €, a solvency of 99.8% of total assets.
Who manages Newton Biocapital II?
The register lists 12 active mandates at Newton Biocapital II. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Newton Biocapital II within its sector?
By total assets for 2025, Newton Biocapital II ranks among the 100 largest of the 210 companies in its sector (NACE 6431) in Belgium that filed accounts for that financial year.
The full file of Newton Biocapital II
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →